Article Details

The Goldman Sachs Group Increases Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $77.00

Retrieved on: 2024-04-20 16:51:27

Tags for this article:

Click the tags to see associated articles and topics

The Goldman Sachs Group Increases Intra-Cellular Therapies (NASDAQ:ITCI) Price Target to $77.00. View article details on HISWAI: https://www.defenseworld.net/2024/04/20/the-goldman-sachs-group-increases-intra-cellular-therapies-nasdaqitci-price-target-to-77-00.html

Summary

The article discusses investing in Intra-Cellular Therapies, detailing stock price movements, analyst ratings and target price adjustments, insider transactions, and institutional investments in the context of equity securities and financial regulation within the stock market.

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up